Actions

Per-protocol analysis

From TrialTree Wiki

Revision as of 22:03, 27 March 2025 by Lawrence (talk | contribs) (Created page with "= Per-Protocol (PP) Analysis = '''Per-Protocol (PP) Analysis''' evaluates the effect of an intervention among participants who fully adhered to the assigned treatment protocol. In contrast to Intention-to-Treat (ITT) analysis, which includes all randomized participants regardless of adherence, PP analysis estimates the efficacy of an intervention under ideal conditions. == 1. When to Use Per-Protocol Analysis == PP analysis is particularly useful in specific scenarios...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Per-Protocol (PP) Analysis

Per-Protocol (PP) Analysis evaluates the effect of an intervention among participants who fully adhered to the assigned treatment protocol. In contrast to Intention-to-Treat (ITT) analysis, which includes all randomized participants regardless of adherence, PP analysis estimates the efficacy of an intervention under ideal conditions.

1. When to Use Per-Protocol Analysis

PP analysis is particularly useful in specific scenarios:

  • When assessing the true biological or mechanistic effect of an intervention.
  • In studies where adherence is essential to achieving the treatment effect (e.g., dietary or behavioral trials).
  • As a complement to ITT analysis for sensitivity or subgroup analysis.

Example: In a diabetes drug trial, the ITT population includes all randomized participants, while the PP analysis includes only those who took ≥80% of their prescribed doses.

2. Key Considerations

  • Higher risk of bias: Excluding non-adherent participants may introduce selection bias.
  • Loss of randomization benefits: Treatment groups may become unbalanced after exclusions.
  • Limited generalizability: Findings apply only to those who followed the protocol and may not reflect real-world effectiveness.

3. Steps for PP Analysis

1. Define adherence criteria: This should be outlined in the study protocol. Examples include minimum medication adherence (e.g., ≥80%), attendance at a specified number of therapy sessions, or completion of follow-up assessments. 2. Exclude non-adherent participants: Participants who crossed over to another group, missed major follow-up points, or deviated from the protocol are excluded. 3. Analyze the per-protocol population: Conduct statistical analysis using only those who met the adherence threshold.

4. Statistical Methods for PP Analysis

  • Continuous outcomes: Use t-tests, linear regression, or mixed-effects models.
  • Binary outcomes: Apply logistic regression or estimate relative risk.
  • Time-to-event outcomes: Use Kaplan–Meier survival analysis or Cox proportional hazards models.

5. PP vs. ITT Analysis

Comparison of Per-Protocol and Intention-to-Treat Analysis
Aspect Per-Protocol (PP) Intention-to-Treat (ITT)
Population Only adherent participants All randomized participants
Effect Estimate Efficacy (ideal conditions) Effectiveness (real-world)
Bias Risk Higher (due to exclusions) Lower (preserves randomization)
Clinical Relevance Lower Higher

6. Reporting PP Analysis in RCTs

  • Clearly define the adherence criteria used.
  • Report the number and proportion of participants excluded from the ITT population.
  • Compare PP and ITT results as part of a sensitivity analysis.


7. Conclusion

Per-Protocol analysis estimates the ideal efficacy of an intervention but comes with a higher risk of bias. It should be interpreted cautiously and reported alongside ITT analyses as part of a comprehensive trial analysis. Pre-specifying adherence criteria is critical to maintain transparency and minimize bias.